This study demonstrates that there is no benefit of inhaled short-acting ß-agonists prior to bronchoscopy in patients with COPD. The inhalation of salbutamol neither improved safety nor prevented ...
What is the landscape like for COPD treatments at the moment? Today you have two types of bronchodilators. Inhaled drugs that open the airways – beta 2 agonists and antimuscarinics – were ...
Current guidelines recommend use of one or more long-acting inhaled bronchodilators for patients with moderate, severe, or very severe COPD. However, the initial choice of long-acting inhaled ...
N-acetylcysteine (NAC) nebulizer therapy is effective and safe as a short-term (12-week) treatment for reducing phlegm in chronic obstructive pulmonary disease (COPD), according to study findings ...
DirectRx pharmacy was added to the network of pharmacies distributing newly approved COPD therapy Ohtuvayre (ensifentrine) in ...
Klaus Rabe, MD, PhD, chest physician and professor of medicine, University of Kiel, shares the latest clinical discoveries from the BOREAS trial on type 2 inflammation in patients with chronic ...
including bronchodilators, steroid inhalers, and oxygen therapy. Pulmonary rehabilitation: a program that teaches ways to ease COPD symptoms. “Pulmonary rehabilitation can help you learn how to ...
GOLD COPD Report includes updated research and recommendations that reflect shifts in thinking on COPD management.
COPD is the third leading cause of death worldwide ... a third compared to placebo when added to standard therapies like bronchodilators, inhaled or oral corticosteroids to reduce inflammation ...
Adults who did not meet the critical smoking exposure threshold of smoking less than 10 pack-years still had greater risk for COPD and early death.
COPD and BPD: Inhalation of Live Lactobacilli Lessens Lung Inflammation and Improves Lung Function Aug. 21, 2024 — In preclinical models, the inhalation of a mixture of living Lactobacilli ...
In a report released today, Ram Selvaraju from H.C. Wainwright reiterated a Buy rating on Verona Pharma (VRNA – Research Report), with a ...